United States · What does Vida Ventures invest in?
Vida Ventures says it invests in Biomedical, Biotechnology and Pharmaceuticals.
What they do
Transforming biomedical innovations into therapiesFrom their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- $100K – $10M as they say
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- BiomedicalBiotechnologyPharmaceuticals
- Based in
- Los Angeles, United States
- Cold pitches
- Not stated
The record
No rounds observed yet. That is a limit of the sources we read, not a finding about the firm. If it has invested, a round will put it here. Know a round it was in? Tell us.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration8 named
ABArie BelldegrunManaging Member of the General PartneriFiling they signed
AGArjun GoyalManaging Member of the General PartneriFiling they signed
FCFred CohenManagement Committee Member / Voting MemberiForm ADV
HSHelen Susan KimManaging Member of the General PartneriFiling they signed
JKJean-Philippe Kouakou-ZebouahChief Financial Officer and Chief Operating OfficeriForm ADV
LALeonard A PotterManagement Committee MemberiForm ADV
RJRajul JainManaging Member of the General PartneriFiling they signed
SVStefan VitorovicManaging Member of the General PartneriFiling they signed
We also hold 26 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$1.2Bgross assets of its funds, 2 advisers combinedOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- VIDA Ventures Advisors, LLC
- SEC number
- CRD 304396
What they claim to have backed
From their own portfolio page (on their website)
7 of 18 we have independently watched raise
Adcendo ApS DevelopingAktis Oncology DiscoveringAvalyn Pharma DevelopingKronos Bio PursuingPeloton Therapeutics AdvancingProtego Biopharma DedicatedThird Arc BioA2 Biotherapeutics AdvancedAllogene Therapeutics AllogeneicAlterome Therapeutics DevelopingAsklepios BioPharmaceutical FocusedAttovia Therapeutics DevelopingCentessa Pharmaceuticals AInvestorsLB Pharmaceuticals DevelopingNeogene Therapeutics PersonalizedPrecision Medicine GroupVigil Neuroscience Harnessing
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.